Clinical, serological and haemodynamic factors associated with poor outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension: a multicentre retrospective study from Korea
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- RHEUMATOLOGY65(4) · 2026
- 피인용
- Web of Science 1Scopus 1
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2024 4.4
- ISSN
- 1462-0324
저자
- Kang, Ji-Hyoun제1저자Chonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea
- Yoon, JiyeolYonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea
- Song, Jason JungsikYonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea
- Choi, Hyo-JinGachon Univ Gil Hosp, Dept Rheumatol, Incheon, South Korea
- Hong, SeokchanUniv Ulsan, Asan Med Ctr, Dept Internal Med, Div Rheumatol,Coll Med, Seoul, South Korea
- Jeon, Chan HongSoonchunhyang Univ Bucheon Hosp, Dept Internal Med, Div Rheumatol, Bucheon, South Korea
- 이승근Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Internal Med, Div Rheumatol,Sch Med, Busan, South Korea
- Lee, Eun BongSeoul Natl Univ, Dept Internal Med, Div Rheumatol, Coll Med, Seoul, South Korea
- Kim, Sang-HyonKeimyung Univ, Dept Internal Med, Div Rheumatol, Sch Med, Daegu, South Korea
- Choi, Sung-EunChonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea
- Park, Dong-JinChonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea
- Lee, Shin-Seok교신저자Chonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea
초록
Objective: To identify factors associated with adverse outcomes in Korean patients with systemic lupus erythematosus-associated pulmonary arterial hypertension (SLE-PAH) confirmed by right heart catheterization (RHC). Methods: This multicentre retrospective study included 68 patients with SLE-PAH diagnosed by RHC at eight tertiary centres. Baseline demographic, clinical, laboratory and haemodynamic data were collected, along with SLE Disease Activity Index (SLEDAI) scores and PAH-related parameters. Primary endpoint was a composite outcome of worsening PAH symptoms requiring treatment escalation, lung transplantation, death or hospitalization. Univariable and multivariable logistic regression analyses were performed to identify independent predictors. Results: Of 68 patients, 35 (51.3%) experienced composite outcomes. Compared with those without composite outcomes, patients with composite outcomes had significantly shorter baseline 6-min walk distances (P = 0.024), higher tricuspid regurgitation velocity (P = 0.032), higher right ventricular systolic pressure (P = 0.035), higher mean pulmonary arterial pressure (mPAP) (P < 0.001), higher mean physician global assessment scores (P = 0.001), higher mean SLEDAI scores (P = 0.005) and more frequent use of combination PAH therapy (P = 0.033). In multivariable analysis, elevated mPAP (odds ratio (OR) 5.401; 95% confidence interval (CI) 1.129–25.837, P = 0.035), higher SLEDAI (OR 5.495; 95% CI 1.041–29.012, P = 0.045) and combination PAH therapy (OR 1.695; 95% CI 1.015–3.267, P = 0.017) remained independent predictors of composite outcomes. Conclusions: Elevated mPAP, active lupus and use of combination PAH therapy were independently associated with poor outcomes in SLE-PAH, highlighting the relevance of comprehensive haemodynamic assessment and careful management of lupus activity.
키워드
catheterizationpulmonary arterial hypertensionright heart systemsystemic lupus erythematosus
식별자
- Scopus EID
- 2-s2.0-105035442789
- WoS UID
- 001735324400001



로그인
연구물 목록으로